Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy (ARCTIC)

This study has been completed.

Sponsor:

Collaborators:

Allies in Cardiovascular Trials Initiatives and Organized Networks:ACTION

Institut National de la Santé Et de la Recherche Médicale, France

Sanofi

Bristol-Myers Squibb

Medtronic

Cordis Corporation

Fondation de France

Diagnostica Stago

Boston Scientific Corporation

Information provided by (Responsible Party):

Assistance Publique - Hôpitaux de Paris

ClinicalTrials.gov Identifier:

NCT00827411

First received: January 13, 2009

Last updated: April 11, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2013
Primary Completion Date:	March 2012 (Final data collection date for primary outcome measure)

Publications: